Brenda L Gallie, MD

Contact information

Send an email
Ophthalmic Oncologist

Education and Fellowships

Royal College of Physicians and Surgeons Canada

Current Positions

Head Retinoblastoma Program
Hospital for Sick Children


Dr. Brenda Gallie, an Ophthalmologist, is President of the International Retinoblastoma Consortium, Director of the Retinoblastoma Program at the Hospital for Sick Children, Paediatric Ocular Oncologist at Calgary Children’s Hospital, Professor at the University of Toronto, and Adjunct Scientist and Lead of Health Informatics Research in the University Health Network TECHNA Institute. Dr. Gallie completed a MD at Queen’s University, Residency at the University of Toronto and post-graduate research training at Memorial Sloan-Kettering Cancer Center. Dr. Gallie was appointed to the Order of Canada in 2014 in recognition of her pioneering research in retinoblastoma that has advanced understanding of cancer genetics, and improved diagnosis and treatment of retinoblastoma. Dr. Gallie has amassed an unprecedented global network of retinoblastoma experts. Leveraging this network, Dr. Gallie developed with her Health Informatics Research Team at the TECHNA Institute, a novel point-of-care database that enhances communication across the health care team, including patents, and supports quality of care by providing a “checklist” approach to each patient. Both care-givers and families find enhanced efficiency and disease understanding through the accessible clear data, rewarding their participation, so indexing every child diagnosed with retinoblastoma – globally – is clearly feasible and teaches safe innovations to improve quality of care. This unique research including ALL children will iteratively achieve a Learning Health system to make retinoblastoma a “Zero Death” cancer. Beyond retinoblastoma, this project illustates a novel approach to healthcare optimization for other complex, rare, and not so rare disease.

The Eye Cancer Network is supported by The Eye Cancer Foundation.
Help support eye cancer research and education now »